Featured Product
This Week in Quality Digest Live
FDA Compliance Features
Jill Roberts
Another way to know what’s too old to eat
Patricia Santos-Serrao
Four pharma quality trends
Del Williams
Preventing damage caused by large, suspended particles
Kari Miller
An effective strategy requires recruiting qualified personnel familiar with the process and technology

More Features

FDA Compliance News
Now is not the time to skip critical factory audits and supply chain assessments
Google Docs collaboration, more efficient management of quality deviations
Delivers time, cost, and efficiency savings while streamlining compliance activity
First trial module of learning tool focuses on ISO 9001 and is available now
Free education source for global medical device community
Good quality is adding an average of 11 percent to organizations’ revenue growth
Further enhances change management capabilities
Creates adaptive system for managing product development and post-market quality for devices with software elements
VQIP allows for expedited review and importation for approved applicants that demonstrate safe supply chains

More News

Quality Digest

FDA Compliance

U.K. Medicines Trade Balance Dips

Published: Wednesday, October 26, 2005 - 22:00

The balance of trade in medicines for the United Kingdom dipped over the first half of 2005. The Association of the British Pharmaceutical Industry reports that there was a 14-percent drop in the trade balance over the first six months of 2005 as compared with the first half of 2004—from 1.693 billion to 1.449 billion British pounds. This was caused by a slight drop in exports over the January to June period, and a small rise in imports over the same period. The ABPI warned in April that several key markers indicating the health of the industry—including trade balance—had dropped.

“These figures seem to confirm that there is cause for concern,” says Richard Barker, ABPI director general. “While the dip is small—and, of course, is only over six months rather than the full year—it sounds another warning signal.”

Pharmaceutical manufacturers are finding that the U.K.’s business climate is less favorable to them than in the past. Other countries offer incentives for local drug manufacturers, reports the ABPI.

“We are therefore engaging with the government about how best to retain the British pharmaceuticals manufacturing base, which has contributed so strongly to our balance of trade and levels of skilled employment,” says Barker.

For more information, visit www.abpi.org.uk.

Discuss

About The Author

Quality Digest’s picture

Quality Digest

For 40 years Quality Digest has been the go-to source for all things quality. Our newsletter, Quality Digest, shares expert commentary and relevant industry resources to assist our readers in their quest for continuous improvement. Our website includes every column and article from the newsletter since May 2009 as well as back issues of Quality Digest magazine to August 1995. We are committed to promoting a view wherein quality is not a niche, but an integral part of every phase of manufacturing and services.